An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

  • STATUS
    Recruiting
  • End date
    Jan 2, 2029
  • participants needed
    800
  • sponsor
    Bristol-Myers Squibb
Updated on 11 July 2022
cancer
arthritis
abatacept

Summary

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Details
Condition Juvenile Idiopathic Arthritis
Clinical Study IdentifierNCT01357668
SponsorBristol-Myers Squibb
Last Modified on11 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosis of JIA (any subtype)
Age < 18 years at the time of enrollment unless currently or previously enrolled in an abatacept clinical trial and received abatacept
Receiving Abatacept at the time of enrollment as per treating physician's decision or received abatacept in a clinical trial
Parent or legally acceptable representative willing to participate in the study and sign the informed consent

Exclusion Criteria

Pregnant or nursing female at the time of enrollment
Prior malignancies if the patient has not been malignancy free for at least 5 years
Any serious acute or chronic medical condition other than JIA, including chronic infection, which would compromise the patient's ability to participate in the study
Known poor compliance with clinic visits (based on physician judgment)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note